Rapport Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Rapport Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapport Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapport Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $47M | 1.6M | 29.70 |
| 2025-06-30 | $14M | 1.2M | 11.37 |
| 2025-03-31 | $12M | 1.2M | 10.03 |
| 2024-12-31 | $13M | 757k | 17.74 |
| 2024-09-30 | $12M | 576k | 20.48 |